2024-10-15 09:52:51 am | Source: StoxBox
Views on HCL Tech - Q2FY25 Results review by Sagar Shetty, Research Analyst, StoxBox
Below the Views on HCL Tech - Q2FY25 Results review by Sagar Shetty, Research Analyst, StoxBox
HCL Tech reported healthy financial performance during the quarter, beating estimates on all fronts. The topline growth was driven by key deal wins across verticals, product offerings and geographies, with the Telecommunications, Media, Publishing & Entertainment vertical recording a solid 61.2% YoY CC growth, while Financial Services continued to be under pressure due to State Street disinvestment. The EBIT margin also stayed within the guidance range of 18-19% driven by positive operating leverage in the ER&D business. A lower attrition rate further highlights easing concerns on the talent pool. The management also raised its lower-end guidance for revenue growth from 3% to 3.5%, highlighting its growing confidence in the business environment especially the next-generation technologies. We expect visible growth in H2FY25, with the impact of State Street receding. Going ahead, the management’s commentary on aspects like demand environment, TCV outlook, guidance for H2FY25 and attrition rate would be key factors to watch.
Above views are of the author and not of the website kindly read disclaimer
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
High-Intensity Interval Training (HIIT) Benefits: A ...
Buy L&T Finance Ltd For Target Rs 330 By Emkay Globa...
Rupee Under Stress: Understanding Forex Volatility i...
Buy Varun Beverages Ltd For Target Rs 13,000 By Emka...
April inflation reflects relatively stable price con...
Buy Sun Pharma Ltd For Target Rs 13,000 By Emkay Glo...
Indian economy has shown resilience in times of glob...
The Index can short at current price for the potenti...
India agrees to supply fertiliser as Nepal faces sho...
Buy UltraTech Cement Ltd For Target Rs 13,000 By Emk...
More News
Quote on FPI from Dr. V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services
Quote on Tuhin Kanta Pandey being appointed as SEBI`s new chairperson by Dr. Manoranjan Sharma, Infomerics Ratings
Quote on Bajaj Auto`s Q3FY25 Results by Arun Agarwal, VP Fundamental Research, Kotak Securities
Food for Thought - Case for Growth Investing in India by Vinay Paharia, CIO, PGIM India Mutual Fund
